These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8971462)

  • 21. Botulinum toxin in the management of acquired motor fusion deficiency.
    Murthy R; Kesarwani S
    Indian J Ophthalmol; 2009; 57(6):463-4. PubMed ID: 19861751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum toxins. Introduction.
    Klein AW
    Semin Cutan Med Surg; 2001 Jun; 20(2):69-70. PubMed ID: 11474746
    [No Abstract]   [Full Text] [Related]  

  • 23. The increasing popularity of Botox injections.
    Zaidi Z
    J Pak Med Assoc; 2007 Feb; 57(2):53-5. PubMed ID: 17370783
    [No Abstract]   [Full Text] [Related]  

  • 24. Improvement in reading symptoms following botulinum toxin A injection for convergence insufficiency type intermittent exotropia.
    Saunte JP; Christensen T
    Acta Ophthalmol; 2015 Aug; 93(5):e391-e392. PubMed ID: 25516206
    [No Abstract]   [Full Text] [Related]  

  • 25. Combining ultrasonography and electromyography for botulinum chemodenervation treatment of thoracic outlet syndrome: comparison with fluoroscopy and electromyography guidance.
    Jordan SE; Ahn SS; Gelabert HA
    Pain Physician; 2007 Jul; 10(4):541-6. PubMed ID: 17660852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action of botulinum toxin on isometric contraction of medial and lateral rectus muscles in esotropic or exotropic patients.
    Santos EA; Lira RP; Bicas HE; Gaete MI
    J Pediatr Ophthalmol Strabismus; 2011; 48(1):38-44. PubMed ID: 20438035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Denervation of mimic muscles during endoscopic lifting of the upper part of face].
    Pinchuk VD; Tkach OS
    Klin Khir; 2013 Aug; (8):72-4. PubMed ID: 24171296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hemifacial spasm with botulinum A toxin].
    Duzyński W; Sławek J
    Neurol Neurochir Pol; 1998; 32 Suppl 1():61-9. PubMed ID: 9608555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrical activation of the orbicularis oculi muscle does not increase the effectiveness of botulinum toxin type A in patients with blepharospasm.
    Conte A; Fabbrini G; Belvisi D; Marsili L; Di Stasio F; Berardelli A
    Eur J Neurol; 2010 Mar; 17(3):449-55. PubMed ID: 19968711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Botulinum A toxin treatment in patients with oromandibular dystonia with concomitant malnutrition].
    Budrewicz S; Koszewicz M; Góral M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():55-60. PubMed ID: 15098332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Indications for Botulinum Toxin in the Management of Strabismus.
    Wagner RS
    J Pediatr Ophthalmol Strabismus; 2016; 53(2):79. PubMed ID: 27018880
    [No Abstract]   [Full Text] [Related]  

  • 32. [The current approach to hyper-sialorrhea].
    Defossez W
    Rev Belge Med Dent (1984); 2006; 61(3):173-9. PubMed ID: 17408138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are there any drawbacks to smoothing out lines and wrinkles with Botox injections?
    Johns Hopkins Med Lett Health After 50; 2014 Jul; 26(6):7. PubMed ID: 25178125
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of botulinum toxin type A to prevent widening of facial scars.
    Wilson AM
    Plast Reconstr Surg; 2006 May; 117(6):1758-66; discussion 1767-8. PubMed ID: 16651948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin A in the treatment of adherence syndrome.
    Ozkan SB; Kir E; Dayanir V; Dündar SO
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):391-5. PubMed ID: 14509463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of essential infantile esotropia with botulinum toxin A: review and recommendations.
    McNeer KW; Tucker MG; Spencer RF
    J Pediatr Ophthalmol Strabismus; 2000; 37(2):63-7; quiz 101-2. PubMed ID: 10779262
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: "Botulinum toxin type A as a migraine preventive treatment" (Silberstein S, Mathew N, Saper J, Jenkins S, for the BOTOX Migraine Clinical Research Group. Headache. 2000;40:445-450).
    Zlotnik G
    Headache; 2001 Jun; 41(6):606. PubMed ID: 11437902
    [No Abstract]   [Full Text] [Related]  

  • 38. Improved functional recovery after facial nerve reconstruction by temporary denervation of the contralateral mimic musculature with botulinum toxin in rats.
    Guntinas-Lichius O; Glowka TR; Angelov DN; Irintchev A; Neiss WF
    Neurorehabil Neural Repair; 2011 Jan; 25(1):15-23. PubMed ID: 20930211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: "Comparison of preferences between onabotulinumtoxinA (Botox) and incobotulinumtoxinA (Xeomin) in the treatment of benign essential blepharospasm".
    Giacometti J; Yen MT
    Ophthalmic Plast Reconstr Surg; 2014; 30(1):76-7. PubMed ID: 24398499
    [No Abstract]   [Full Text] [Related]  

  • 40. Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning.
    Ben Simon GJ; Blaydon SM; Schwarcz RM; Nakra T; Goldberg RA; McCann JD
    Ophthalmology; 2005 May; 112(5):918-22. PubMed ID: 15878076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.